The Metastases Spinal Tumor Market is expected to grow at a CAGR of 5% during the forecast period 2022-2028. Metastatic spinal tumors are one of the most common problems in oncology. About 5%-10% of cancer patients face metastatic disease of the spine. Most metastatic spinal tumors develop outside the dura (epidural). About 70% of spine […]
